Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
UPSC Notes
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a condition in which excess fat accumulates in the liver in association with at least one cardiometabolic risk factor.
The term MASLD replaced the older term non-alcoholic fatty liver disease (NAFLD) in updated disease nomenclature.
Major risk factors
Overweight and obesity.
Type 2 diabetes.
Abnormal blood lipid levels.
High blood pressure and other metabolic risk factors.
Physical inactivity and certain dietary patterns.
Potential consequences
Fat accumulation in liver cells.
Inflammation and liver-cell injury in some patients.
Progression to liver fibrosis.
In advanced cases, cirrhosis and increased risk of liver-related complications.
Key Pointers for UPSC
Full form: Metabolic Dysfunction-Associated Steatotic Liver Disease.
MASLD is associated with metabolic dysfunction.
It is not simply another name for alcoholic liver disease.
Diagnosis can involve medical history, blood tests, imaging and assessment of liver fibrosis.
Weight management, physical activity and control of metabolic risk factors are important prevention and management strategies.
MASLD may remain asymptomatic for years, so absence of symptoms does not rule it out.
Share this article